Celine S. Dufetel
Known title: DirectorCIK: 0001731465
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
T. Rowe Price Faces Advisor Hiring Push and Dividend Debate. T. Rowe Price is testing its growth strategy with a new advisor hiring push, while analysts note a modest fair‑value cut amid mixed views. The firm’s dividend yield of 4.97% keeps it in the conversation with other dividend leaders, and a recent 38% share drop has led some to label it undervalued. Earnings expectations are being watched closely as the company prepares its next quarterly report.
Transaction History
| FISV | ▲ Buy | Grant | 4,121 | $0 | 5/21/2026 | View on chart |
| FISV | ▲ Buy | Grant | 1,314 | $0 | 1/1/2026 | View on chart |
| TROW | ▼ Sell | Other | 7,824 | $0 | 8/31/2021 | View on chart |
| TROW | ▼ Sell | Other | 8,161 | $0 | 8/31/2021 | View on chart |
| TROW | ▼ Sell | Other | 1,769 | $0 | 8/31/2021 | View on chart |
| TROW | ▼ Sell | Other | 5,795 | $0 | 8/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Fiserv faces price target cuts and rating changes as stock slides 48%
Fiserv’s shares have fallen about 48% from their 52‑week high. Analysts have adjusted their views, with Cantor keeping a neutral stance while lowering its price target to $48, and BofA reinstating an underperform rating and also setting a $48 target as it resumes payments coverage. Litigants noted a recent ‘reset’ in a legal case involving the company. The stock was also named among the top three financial picks in a sector review.
Fiserv faces price target cuts and rating changes as stock slides 48%. Fiserv’s shares have fallen about 48% from their 52‑week high. Analysts have adjusted their views, with Cantor keeping a neutral stance while lowering its price target to $48, and BofA reinstating an underperform rating and also setting a $48 target as it resumes payments coverage. Litigants noted a recent ‘reset’ in a legal case involving the company. The stock was also named among the top three financial picks in a sector review.